902836-46-8

Basic information

• Product Name: 3-METHYL-5-PYRROLIDIN-3-YL-1,2,4-OXADIAZOLE
• Synonyms: 3-METHYL-5-PYRROLIDIN-3-YL-1,2,4-OXADIAZOLE;3-Methyl-5-(3-pyrrolidinyl)-1,2,4-oxadiazole;1,2,4-Oxadiazole, 3-Methyl-5-(3-pyrrolidinyl)-
• CAS NO: 902836-46-8
• Molecular Formula: C7H11N3O
• Molecular Weight: 153.18
• Mol File: 902836-46-8.mol
• Article Data: 3

Chemical Properties

• Melting Point: 96-97°C/0.5mm
• Boiling Point: 281℃
• Flash Point: 124℃
• Appearance: /
• Density: 1.139
• Vapor Pressure: 0.00109mmHg at 25°C
• Refractive Index: 1.473
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 3-METHYL-5-PYRROLIDIN-3-YL-1,2,4-OXADIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHYL-5-PYRROLIDIN-3-YL-1,2,4-OXADIAZOLE(902836-46-8)
• EPA Substance Registry System: 3-METHYL-5-PYRROLIDIN-3-YL-1,2,4-OXADIAZOLE(902836-46-8)

Safety Data

• Statements: Xi:刺激性物质
• Hazardous Substances Data: 902836-46-8(Hazardous Substances Data)

Usage

General Description

3-Methyl-5-Pyrolidin-3-yl-1,2,4-Oxadiazole is a unique chemical compound that is composed of different atoms including carbon, hydrogen, nitrogen, and oxygen. The specific structure includes a methyl group, an oxadiazole ring, and a pyrrolidinyl substituent, making it part of both the oxadiazole and pyrrolidine families of organic compounds. This specific structure may lend this compound specific chemical properties, reactivity and functionality. As it is quite an uncommon and specific chemical, information on its specific uses or production is scarce, indicating that it may be primarily used in specialized chemical research or unique industrial applications.

InChI:InChI=1/C12H14F3NO/c13-12(14,15)10-3-1-2-4-11(10)17-9-5-7-16-8-6-9/h1-4,9,16H,5-8H2

Relevant articles and documents

COGNITION ENHANCING COMPOUNDS AND COMPOSITIONS, METHODS OF MAKING, AND METHODS OF TREATING

The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine, receptors and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans. The compositions comprising a muscarinic agonist or a pharma.ceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.

COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING

Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.